Literature DB >> 16426242

The role of HLA molecules in susceptibility to chronic rheumatic heart disease.

H Kudat1, G Telci, A B Sozen, F Oguz, V Akkaya, M Ozcan, D Atilgan, M Carin, O Guven.   

Abstract

Only a small fraction of the streptococcal pharyngitis progress to rheumatic carditis, which implies that environmental, host and microbial factors interact to cause an aberrant immune response against the antigens of the microorganism that cross-react with cardiac tissues. Although there are numerous studies and a general consensus on the relation between human leucocyte antigen (HLA) class II antigens and rheumatic heart disease (RHD), the details and the culprit antigens are still controversial. The study was undertaken to examine 100 patients with chronic RHD and 100 controls for HLA class I and class II antigens for differences in prevalence. All samples were typed at the HLA-DRB1/3/4/5 and DQB1 loci by the sequence-specific primer (PCR-SSP) method at low resolution. For HLA class I antigens, HLA-B13 frequency was marginally increased in patients with RHD compared to controls without reaching statistical significance. For class II antigens, RHD patients had higher frequencies for HLA-DRB1*01 (RHD 24%, controls 10%), DRB1*04 (RHD 35%, controls 26%), DRB1*07 (RHD 18%, controls 11%) and HLA-DQB1*02 (RHD 32%, controls 17%) without reaching statistical significance, and significantly lower frequencies for DRB1*13 (Pc < 0.003, OR: 5.69), DRB5* (Pc < 0.003, OR: 33) and DRB3* (Pc = 0.03, OR: 2.66) compared to controls. It was concluded that host, microbial and environmental factors collude to create acute rheumatic fever (RF) and chronic rheumatic valve disease. The HLA-DRB1*13, DRB5* and DRB3* were protective against the development of rheumatic valve damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426242     DOI: 10.1111/j.1744-313X.2006.00562.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  6 in total

Review 1.  Infection and autoimmune disease.

Authors:  Asli Gamze Sener; Ilhan Afsar
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

2.  Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant TFH cells.

Authors:  Jennifer M Dan; Colin Havenar-Daughton; Kayla Kendric; Rita Al-Kolla; Kirti Kaushik; Sandy L Rosales; Ericka L Anderson; Christopher N LaRock; Pandurangan Vijayanand; Grégory Seumois; David Layfield; Ramsey I Cutress; Christian H Ottensmeier; Cecilia S Lindestam Arlehamn; Alessandro Sette; Victor Nizet; Marcella Bothwell; Matthew Brigger; Shane Crotty
Journal:  Sci Transl Med       Date:  2019-02-06       Impact factor: 17.956

Review 3.  The Genetic Control of the Rheumatic Heart: Closing the Genotype-Phenotype Gap.

Authors:  Atiyeh M Abdallah; Marawan Abu-Madi
Journal:  Front Med (Lausanne)       Date:  2021-03-24

4.  Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis.

Authors:  Seungbok Lee; Seung Hwan Paik; Hyun-Jin Kim; Hyeong Ho Ryu; Soeun Cha; Seong Jin Jo; Hee Chul Eun; Jeong-Sun Seo; Jong-Il Kim; Oh Sang Kwon
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

5.  HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.

Authors:  Valda Stanevicha; Jelena Eglite; Dace Zavadska; Arturs Sochnevs; Ruta Shantere; Dace Gardovska
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

6.  Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study.

Authors:  Emmy Okello; Andrea Beaton; Charles K Mondo; Paul Kruszka; Noah Kiwanuka; Richard Odoi-Adome; Juergen Freers
Journal:  BMC Cardiovasc Disord       Date:  2014-02-28       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.